Emeco locks in CEO Ian Testrow through to 2031 with performance-weighted pay overhaul
Emeco Holdings (ASX: EHL) has agreed revised employment arrangements with Managing Director and Chief Executive Officer Ian Testrow, extending his tenure through to 30 June 2031. Announced on 23 July 2026, the agreement builds on prior terms that ran until 30 June 2027, making this an extension of an existing contract rather than a new appointment.
The revised arrangements are intended to support leadership continuity as Emeco executes what the Board describes as the next phase of its corporate strategy. A greater share of Testrow’s pay will now be tied to performance outcomes.
Six consecutive halves of earnings growth, alongside a balance sheet transformation that brought net leverage down to 0.5x, form the operational backdrop against which the Board decided to lock in leadership continuity through to FY31.
Under the extended contract, total fixed remuneration (TFR) is set at $1,610,000 per annum (inclusive of superannuation) from 1 July 2027, reviewed annually to reflect inflationary adjustments. The company noted it will seek shareholder approvals as required to implement the changes.
When big ASX news breaks, our subscribers know first
What the new contract changes, and what stays the same
Key terms of the agreement remain broadly unchanged from those in effect until 30 June 2027. The main structural shift is a heavier weighting towards performance-linked pay, with the introduction of a stretch component to both incentive plans lifting total participation to 300% of TFR.
The table below summarises the revised remuneration structure applying across the Further Variation Period.
| Component | Target | Stretch Component | Notes |
|---|---|---|---|
| STI plan | 130% of TFR | +20% of TFR | Payable in cash and/or equity at Mr Testrow’s election |
| LTI plan | 120% of TFR | +30% of TFR | All awards in equity; FY28–FY31 plans use a one-year performance period and VWAP-based entitlement |
| Total participation | — | — | Up to 300% of TFR |
Several vesting and equity mechanics apply to the arrangement:
-
All short-term incentive (STI) and long-term incentive (LTI) equity awards granted during the Further Variation Period will vest on the earlier of the release of the company’s FY31 full-year results or the end of Mr Testrow’s employment.
-
Any STI or LTI awards not approved by shareholders will be paid in cash.
-
The loan made to Mr Testrow, approved by shareholders at the company’s 2023 AGM, is to be extended to 30 June 2031, being the end of the Further Variation Period.
For the LTI plans covering FY28 to FY31 inclusive, entitlement will be calculated using a volume weighted average price, and the plans will use a one-year performance period.
Why performance-linked pay matters for shareholders
Investors often view a higher proportion of at-risk pay favourably, because it links what an executive earns to the value delivered to shareholders. With total incentive participation now reaching up to 300% of TFR, a larger portion of Testrow’s potential earnings depends on performance outcomes rather than fixed salary.
The single vesting point at FY31 results also creates a long-term retention and delivery incentive, encouraging the CEO to remain in place and drive results across the full period.
Emeco’s FY26 trading update points to Operating EBITDA of $290-$295 million and net leverage at 0.4x, the financial platform that the Board cited when framing the rationale for extending Testrow’s tenure through to 2031.
Emeco Chair Ian Macliver
“The Board recognises Mr Testrow’s operational leadership and contribution to Emeco’s strategic repositioning. The revised arrangements support continuity of leadership as Emeco executes the next phase of its corporate strategy, while increasing the proportion of remuneration subject to performance outcomes to further align with shareholder value creation.”
Protective provisions and next steps
The contract retains a set of termination, disability and change-of-control provisions. These are unchanged other than being extended to apply across the Further Variation Period, subject to shareholder approval where relevant.
-
Termination — Mr Testrow’s employment can only be terminated in specified circumstances, such as serious misconduct, material breach of policy or other similarly serious circumstances. Post-employment restraints apply until 30 June 2031.
-
Early resignation — If Mr Testrow resigns after commencement of the Further Variation Period and his employment ends before 30 June 2031, the loan attracts an interest rate of 12% per annum from the date it was drawn until his employment ends and he repays the loan. Equity incentives tested and awarded prior to that date are received, while any incentives for part years worked or not yet worked are forfeited.
-
Disability, death or change of control — Unpaid TFR (or an equivalent amount) up to 30 June 2031 will be paid, and the maximum untested LTI equity available will vest or otherwise be cash-settled.
All incentive and equity terms are subject to shareholder approval. Where approval is not obtained, the relevant awards will be paid in cash rather than equity.
Emeco will seek the requisite shareholder approvals to implement the changes. No specific meeting date was disclosed in the announcement.
Stay Ahead on ASX Industrials News
Big News Blast delivers FREE breaking ASX announcements directly to your inbox within minutes of release, complete with in-depth analysis already done. Join 20,000+ active subscribers who get market-moving news before the broader market catches on. Click the “Free Alerts” button at StockWire X to start receiving alerts today.